Article
Andrew Dunn for Business Insider
Jun 29 ’20The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir
We found this article at:
auteur
Get notified of new articles from this auteur
Andrew Dunn
Business Insider